Table 3:
Proportion of participants with clinically meaningful improvement in average pain intensity and proportion endorsing any opioid analgesic medication use at each follow-up time by treatment group (no imputed data), and risk ratios comparing treatment groups
| Proportion (95% Confidence Interval)a | P-valueb | Risk Ratio (95% Confidence Interval)e | ||||||
|---|---|---|---|---|---|---|---|---|
| ED | HYP | MM | HYP vs. ED | MM vs. ED | MM vs. HYP | |||
| Clinically Meaningful Responder (yes) | Post-treatment | 0.16 (0.09, 0.24) | 0.12 (0.06, 0.19) | 0.20 (0.13, 0.29) | .29 | 0.75 (0.37, 1.51) | 1.27 (0.69, 2.35) | 1.70 (0.57, 2.83) |
| 3-months | 0.17 (0.10, 0.26) | 0.20 (0.13, 0.29) | 0.18 (0.11, 0.27) | .80 | 1.20 (0.65, 2.19) | 1.01 (0.52, 1.93) | 0.84 (0.33, 1.36) | |
| 6-months | 0.09 (0.04, 0.17) | 0.26 (0.18, 0.36) | 0.22 (0.15, 0.32) | .02* | 2.85 (1.35, 6.00)* | 2.35 (1.09, 5.08)* | 0.83 (0.39, 1.26) | |
| Using any opioid analgesic Medications (yes) | Post-treatment | 0.24 (0.16, 0.33) | 0.20 (0.13, 0.29) | 0.22 (0.15, 0.32) | .003* | 1.40 (1.11, 1.78)* | 0.97 (0.69, 1.37) | 0.69 (0.52, 0.86)* |
| 3-months | 0.23 (0.15, 0.33) | 0.20 (0.13, 0.29) | 0.26 (0.17, 0.36) | .05* | 1.28 (0.97, 1.68) | 0.96 (0.67, 1.36) | 0.75 (0.54, 0.96)* | |
| 6-months | 0.25 (0.16, 0.35) | 0.21 (0.14, 0.31) | 0.24 (0.16, 0.34) | .18 | 1.17 (0.87, 1.57) | 0.85 (0.58, 1.24) | 0.73 (0.47, 0.98) | |
Denotes significance at p < .05
Proportions based on complete dataset, and Jeffreys 95% confidence intervals
P-value from omnibus test for treatment group effect on being a responder to treatment (adjusting for pretreatment average pain intensity) or using opioid analgesic medications (adjusting for use at pretreatment) in a logistic regression.
Risk ratio estimates from a logistic regression with log-link for a responder to treatment (adjusting for pretreatment average pain intensity) or using opioid analgesic medication at posttreatment (adjusting for use at pretreatment)